MediWound Ltd. (MDWD) News Headlines

▮ More

Date

Headline

7/11/2022 7:44:55 AM MediWound Reveals Positive Initial Data Of MW005 In Phase I/II Study To Treat Basal Cell Carcinoma

7/11/2022 7:14:59 AM MediWound Announces Positive Initial Data From U.S. Phase I/II Study Of MW005 For Basal Cell Carcinoma

7/7/2022 7:17:30 AM MediWound Reports Positive Results From Phase 2 Pharmacology Study Of EscharEx

7/7/2022 7:07:49 AM MediWound Announces Positive Results From Phase 2 Pharmacology Study Of EscharEx

3/18/2022 6:15:42 AM APYX Sees 3-30% Revenue Growth, AVDL Awaits FDA Decision, KZR To Report MISSION Data In Q2...

3/17/2022 7:24:40 AM MediWound Q4 Loss Per Share $0.50 Vs Loss $0.34 Last Year

1/24/2022 6:06:33 AM MediWound Announces Positive Topline Results From U.S. Phase 2 Trial Of EscharEx For Debridement Of Chronic Wounds

Older Articles

Mediwound Ltd. (MDWD)